Financial toxicity and symptom burden: what is the big deal?

Loading...
Thumbnail Image
File version

Accepted Manuscript (AM)

Author(s)
Chan, Raymond Javan
Gordon, Louisa
Zafar, Syed Yousuf
Miaskowski, Christine
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2018
Size
File type(s)
Location
License
Abstract

There is great interest currently on the issue of financial toxicity (FT) in cancer care with research papers, commentaries, and press articles on the topic substantially growing. The term ‘FT’ is used to describe the financial distress or hardship as an outcome of cancer treatment [1]. Alleviating the impact of FT requires knowledge of how health services are organised and funded within the respective health system and the efforts of numerous groups including policy makers, clinicians, advocacy groups, and industry. The supportive care community has taken the mission of lessening the negative impact of FT very seriously. Regardless of how it is measured, relatively high levels of FT are experienced by oncology patients and their caregivers [1]. Our recent systematic review of the FT literature found that the frequency of FT ranged from 28 to 48% using monetary measures like percentage of household income, and 16 to 73% using self-report measures such as impacts on everyday living expenses [1].

Journal Title

SUPPORTIVE CARE IN CANCER

Conference Title
Book Title
Edition
Volume

26

Issue

5

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2018 Springer Berlin/Heidelberg. This is an electronic version of an article published in Supportive Care in Cancer, May 2018, Volume 26, Issue 5, pp 1357–1359. Supportive Care in Cancer is available online at: http://link.springer.com/ with the open URL of your article.

Item Access Status
Note
Access the data
Related item(s)
Subject

Biomedical and clinical sciences

Psychology

Persistent link to this record
Citation
Collections